Annexon Inc. (ANNX)
NASDAQ: ANNX
· Real-Time Price · USD
3.19
0.08 (2.57%)
At close: Oct 03, 2025, 3:59 PM
3.21
0.63%
After-hours: Oct 03, 2025, 06:16 PM EDT
2.57% (1D)
| Bid | 3.19 |
| Market Cap | 350.52M |
| Revenue (ttm) | 3.4M |
| Net Income (ttm) | -186.93M |
| EPS (ttm) | -1.29 |
| PE Ratio (ttm) | -2.47 |
| Forward PE | -2.29 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 3.38 |
| Volume | 1,482,222 |
| Avg. Volume (20D) | 1,800,876 |
| Open | 3.19 |
| Previous Close | 3.11 |
| Day's Range | 3.12 - 3.38 |
| 52-Week Range | 1.28 - 7.85 |
| Beta | 1.37 |
| Ex-Dividend Date | n/a |
About ANNX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ANNX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ANNX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
-5.52%
Annexon shares are trading higher after the compan...
Unlock content with
Pro Subscription
9 months ago
+13.96%
Annexon shares are trading higher after the company announced topline results from a study supporting Anx005 as a potential treatment for Guillain-barré syndrome.
